ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2009/06/09 | 180.8 | 180.8 | 175.5 | 180.8 | +12.5 | +7.4% | 1,127,200 |
| 2009/06/08 | 165.8 | 168.3 | 163.3 | 168.3 | +12.5 | +8% | 410,400 |
| 2009/06/05 | 150.3 | 157.3 | 147.5 | 155.8 | +6.3 | +4.2% | 359,200 |
| 2009/06/04 | 150 | 157.8 | 145 | 149.5 | +4.2 | +2.9% | 1,173,600 |
| 2009/06/03 | 147.8 | 152.3 | 145.3 | 145.3 | -12.5 | -7.9% | 1,033,200 |
| 2009/06/02 | 167.8 | 168.5 | 157.8 | 157.8 | -12.5 | -7.3% | 941,200 |
| 2009/06/01 | 169 | 174 | 166.8 | 170.3 | -7.5 | -4.2% | 572,000 |
| 2009/05/29 | 177 | 187.5 | 176 | 177.8 | +2 | +1.1% | 936,800 |
| 2009/05/28 | 160 | 175.8 | 158.3 | 175.8 | +12.5 | +7.7% | 810,400 |
| 2009/05/27 | 174 | 190 | 154 | 163.3 | -13.2 | -7.5% | 2,495,600 |
| 2009/05/26 | 176.5 | 176.5 | 176.5 | 176.5 | +12.5 | +7.6% | 58,400 |
| 2009/05/25 | 164 | 164 | 164 | 164 | +12.5 | +8.3% | 37,200 |
| 2009/05/22 | 151.5 | 151.5 | 151.5 | 151.5 | +12.5 | +9% | 460,400 |
| 2009/05/21 | 139 | 139 | 137 | 139 | +12.5 | +9.9% | 525,600 |
| 2009/05/20 | 125 | 131.3 | 121.5 | 126.5 | +5.2 | +4.3% | 1,632,400 |
| 2009/05/19 | 118.3 | 124.8 | 115.6 | 121.3 | +6 | +5.2% | 1,540,400 |
| 2009/05/18 | 115.3 | 115.3 | 115.3 | 115.3 | +10 | +9.5% | 64,800 |
| 2009/05/15 | 105.3 | 105.3 | 105.3 | 105.3 | +10 | +10.5% | 54,800 |
| 2009/05/14 | 99.3 | 101.3 | 95.3 | 95.3 | -10 | -9.5% | 337,200 |
| 2009/05/13 | 96.3 | 105.3 | 90.3 | 105.3 | +5 | +5% | 837,600 |
| 2009/05/12 | 100.3 | 101.8 | 100.3 | 100.3 | -10 | -9.1% | 410,000 |
| 2009/05/11 | 107 | 112 | 106.5 | 110.3 | +8.3 | +8.1% | 924,800 |
| 2009/05/08 | 94.5 | 102 | 94.5 | 102 | +5.5 | +5.7% | 589,200 |
| 2009/05/07 | 91.5 | 96.5 | 87.8 | 96.5 | +10 | +11.6% | 838,800 |
| 2009/05/01 | 76.6 | 86.5 | 76.6 | 86.5 | +10 | +13.1% | 871,200 |
| 2009/04/30 | 75.8 | 77.8 | 75.5 | 76.5 | +1.2 | +1.6% | 162,000 |
| 2009/04/28 | 76.3 | 76.3 | 73.9 | 75.3 | ±0 | ±0% | 116,400 |
| 2009/04/27 | 75.8 | 76.8 | 75 | 75.3 | -1.5 | -2% | 122,400 |
| 2009/04/24 | 75.8 | 76.8 | 74 | 76.8 | +2.3 | +3.1% | 145,600 |
| 2009/04/23 | 73.8 | 75.3 | 73.8 | 74.5 | -0.3 | -0.4% | 130,400 |
| 2009/04/22 | 77 | 78 | 74.8 | 74.8 | -2.2 | -2.9% | 143,200 |
| 2009/04/21 | 79.6 | 79.6 | 73.8 | 77 | -1.6 | -2% | 141,200 |
| 2009/04/20 | 73.8 | 79 | 73.8 | 78.6 | +5.6 | +7.7% | 205,600 |
| 2009/04/17 | 72.6 | 74.5 | 72.5 | 73 | ±0 | ±0% | 62,000 |
| 2009/04/16 | 75.4 | 75.4 | 73 | 73 | -3.4 | -4.5% | 134,000 |
| 2009/04/15 | 73.5 | 76.9 | 71.5 | 76.4 | +2.6 | +3.5% | 137,200 |
| 2009/04/14 | 72.8 | 73.8 | 71.3 | 73.8 | +0.5 | +0.7% | 291,200 |
| 2009/04/13 | 75.3 | 75.4 | 73.3 | 73.3 | -2.2 | -2.9% | 175,600 |
| 2009/04/10 | 75.5 | 77.1 | 75 | 75.5 | ±0 | ±0% | 113,600 |
| 2009/04/09 | 76.3 | 77.5 | 74.3 | 75.5 | -1.5 | -1.9% | 147,200 |
| 2009/04/08 | 76.3 | 77.5 | 75.9 | 77 | +1.9 | +2.5% | 59,600 |
| 2009/04/07 | 80 | 80 | 75 | 75.1 | -4.7 | -5.9% | 156,800 |
| 2009/04/06 | 78.8 | 80 | 78 | 79.8 | +2 | +2.6% | 127,200 |
| 2009/04/03 | 78.8 | 79.6 | 76.4 | 77.8 | +0.8 | +1% | 181,200 |
| 2009/04/02 | 75 | 77 | 73.3 | 77 | +4 | +5.5% | 169,200 |
| 2009/04/01 | 72.5 | 73 | 71.3 | 73 | +1.2 | +1.7% | 71,200 |
| 2009/03/31 | 71.4 | 72.5 | 70.9 | 71.8 | +0.2 | +0.3% | 156,000 |
| 2009/03/30 | 73 | 73.6 | 71.6 | 71.6 | -2.3 | -3.1% | 150,000 |
| 2009/03/27 | 75 | 76.1 | 71.3 | 73.9 | -0.3 | -0.4% | 232,400 |
| 2009/03/26 | 71.8 | 74.2 | 70.3 | 74.2 | +1.7 | +2.3% | 128,800 |
3751～
3800
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 127,300円 | +197.7% | - | 0.00% | 52.02倍 | 1.66倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 392,500円 | +11.1% | +20.6% | 3.06% | 22.99倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,000円 | +3.2% | +4.5% | 3.40% | 17.58倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
